Suppr超能文献

用于治疗慢性疼痛的钠通道蛋白1.7抑制剂。

Na1.7 inhibitors for the treatment of chronic pain.

作者信息

McKerrall Steven J, Sutherlin Daniel P

机构信息

Discovery Chemistry, Genentech Inc, 1 DNA Way, South San Francisco, CA 94080, USA.

Discovery Chemistry, Genentech Inc, 1 DNA Way, South San Francisco, CA 94080, USA.

出版信息

Bioorg Med Chem Lett. 2018 Oct 15;28(19):3141-3149. doi: 10.1016/j.bmcl.2018.08.007. Epub 2018 Aug 12.

Abstract

The voltage gated sodium channel Na1.7 plays an essential role in the transmission of pain signals. Strong human genetic validation has motivated extensive efforts to discover potent, selective, and efficacious Na1.7 inhibitors for the treatment of chronic pain. This digest will introduce the structure and function of Na1.7 and highlight the wealth of recent developments on a diverse array of Na1.7 inhibitors, including optimization of their potency, selectivity, and PK/PD relationships.

摘要

电压门控钠通道Na1.7在疼痛信号传递中起关键作用。有力的人类遗传学验证促使人们付出巨大努力来发现强效、选择性且有效的Na1.7抑制剂,用于治疗慢性疼痛。本综述将介绍Na1.7的结构与功能,并重点阐述近期在多种Na1.7抑制剂方面的大量进展,包括对其效力、选择性以及药代动力学/药效学关系的优化。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验